Many of us know someone with Alzheimer’s disease, the most common form of dementia. Over $30 billion has been spent to develop a drug-based cure for it. So far, nothing works.
We are determined to end Alzheimer's disease with Arethusta®, a first-in-class outpatient treatment. Our first mission is to test it by reversing mild cognitive impairment associated with Alzheimer’s disease. Afterward, we intend to use Arethusta to prevent and cure Alzheimer’s itself. Our work is attracting significant attention.
